Skip to content
DataLookout
Menu

VIRTUAL-FRNCT07927699

VItiligo RegisTry adUlts And chiLdren-France

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Clinical course of vitiligo under treatment assessed by T-VASI
Timeframe: Baseline, 6 months, 1 year, and 2 years
Clinical course of vitiligo under treatment assessed by sIGA
Timeframe: Baseline, 6 months, 1 year, and 2 years

Secondary (17)

Descriptive data of BMI
Treatment-related adverse events
Measure of the quality of life
Vitiligo burden
Change in vitiligo disease activity assessed by the Vitiligo Signs of Activity Score (VSAS)
Show 12 moreShow less
Patient Self-reported Vitiligo extent (SA-VES)
Feasibility of the multicenter vitiligo registry
Age of participants at enrollment
Distribution of participants by sex
Number of participants with comorbidities
Number of participants with previous treatments for vitiligo
Number of participants with a history of cancer
F-VASI - Facial extent of vitiligo
VNS - Patient reported Vitiligo noticeability scale (VNS)
PHQ-4 - Patient Health Questionnaire to measure Psychological distress
GAD-7 - Anxiety assessment
PUSH-D - Stigma linked to vitiligo

Arms and interventions

Adults and pediatric Patients with vitiligo

Adults and children with a diagnosis of vitiligo followed in the dermatology department of a participating center. Participants receive routine clinical care for vitiligo. Clinical characteristics, current and previous treatments, treatment-related adverse events, disease severity, quality of life, and patient-reported outcomes are collected during follow-up

Other: Vitiligo treatments in routine clinical practice

Sites

1 site in 1 country

  • Assistance Publique Hôpitaux de ParisCréteil, France